Dr. Bhumika Patel, M.D.
Claim this profileCleveland Clinic - Case Comprehensive Cancer Center
Studies Anemia
Studies Leukemia
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Bhumika Patel, M.D. is currently running
Iptacopan
for Paroxysmal Nocturnal Hemoglobinuria
This study is an open-label, single arm, multicenter, roll-over extension study to characterize long-term safety, tolerability and efficacy of iptacopan and to provide access to iptacopan to patients with PNH who have completed Novartis-sponsored Phase 2 or 3 studies with iptacopan
Recruiting2 awards Phase 33 criteria
Ivosidenib + Venetoclax +/- Azacitidine
for Leukemia
This phase Ib/II trial studies the side effects and best dose of venetoclax and how well it works when given together with ivosidenib with or without azacitidine, in treating patients with IDH1-mutated hematologic malignancies. Venetoclax and ivosidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ivosidenib and venetoclax with azacitidine may work better in treating patients with hematologic malignancies compared to ivosidenib and venetoclax alone.
Recruiting3 awards Phase 1 & 2
More about Bhumika Patel, M.D.
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Bhumika Patel, M.D. has experience with
- Ivosidenib
- Ruxolitinib
- Enasidenib
- Venetoclax
- Azacitidine
- REGN7257
Breakdown of trials Bhumika Patel, M.D. has run
Anemia
Leukemia
Low blood cell count
Clonal Cytopenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bhumika Patel, M.D. specialize in?
Bhumika Patel, M.D. focuses on Anemia and Leukemia. In particular, much of their work with Anemia has involved IDH positive patients, or patients who are undergoing treatment.
Is Bhumika Patel, M.D. currently recruiting for clinical trials?
Yes, Bhumika Patel, M.D. is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Bhumika Patel, M.D. has studied deeply?
Yes, Bhumika Patel, M.D. has studied treatments such as Ivosidenib, Ruxolitinib, Enasidenib.
What is the best way to schedule an appointment with Bhumika Patel, M.D.?
Apply for one of the trials that Bhumika Patel, M.D. is conducting.
What is the office address of Bhumika Patel, M.D.?
The office of Bhumika Patel, M.D. is located at: Cleveland Clinic - Case Comprehensive Cancer Center, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic - Case Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.